RxDoctor Payments Data

Michael Mansour, MD

Internal Medicine · Boston, MANPI 1437285863

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Fisher Scientific Company L.L.C. at 52.5% of the total. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,722in general payments, 2019–2025

Across 21 payments — averaging $1415.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fisher Scientific Company L.L.C.$16K
  • Genmark Diagnostics, Inc.$6K
  • Celularity Inc.$5K
  • Vericel Corporation$2K
  • Cepheid$1K
$2,174,361in research payments, 2019–2025

Across 35 payments — averaging $62,125 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Brahms GmbH$1.5M
  • Roche Molecular Systems, Inc.$328K
  • Beckman Coulter, Inc.$214K
  • Regeneron$132K

What the payments were for

  • Consulting fees$14,11347%
  • Speaking & faculty fees$14,50049%
  • Travel & lodging$1,0554%
  • Food & beverage$540%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Fisher Scientific Company L.L.C.14$15,596
Genmark Diagnostics, Inc.3$5,927
Celularity Inc.1$5,000
Vericel Corporation2$2,000
Cepheid1$1,200

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,722 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$15,597
Medicare patients
43
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →